The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Open accessAbstract
Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors of the adrenal glands and the sympathetic and parasympathetic paraganglia. They can occur sporadically or as a part of different hereditary tumor syndromes. About 30% of PCCs and PGLs are currently believed to be caused by germline mutations and several novel susceptibility genes have recently been discovered. The clinical presentation, including localization, malignant potential, and age of onset, varies depending on the genetic background of the tumors. By reviewing more than 1700 reported cases of hereditary PCC and PGL, a thorough summary of the genetics and clinical features of these tumors is given, both as part of the classical syndromes such as multiple endocrine neoplasia type 2 (MEN2), von Hippel–Lindau disease, neurofibromatosis type 1, and succinate dehydrogenase-related PCC–PGL and within syndromes associated with a smaller fraction of PCCs/PGLs, such as Carney triad, Carney–Stratakis syndrome, and MEN1. The review also covers the most recently discovered susceptibility genes including KIF1Bβ, EGLN1/PHD2, SDHAF2, TMEM127, SDHA, and MAX, as well as a comparison with the sporadic form. Further, the latest advances in elucidating the cellular pathways involved in PCC and PGL development are discussed in detail. Finally, an algorithm for genetic testing in patients with PCC and PGL is proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
The American Journal of Human Genetics
S., J. (1950) · Population (French Edition) · doi:10.2307/1523704 · Cited by 5,028
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
Rao, S. V., & Jollis, J. G. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.10.991 · Cited by 2,217
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 1×
“The succinate accumulation thus inhibits the EGLN enzyme activity, thereby leading to HIF-a stabilization and activation (Selak et al. 2005).”
BackgroundPositional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Self-citationBerra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,314
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P., & Wells, S. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.851 · Cited by 1,303
Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81311-2 · Cited by 1,174
Hofstra, R. M. W., Landsvater, R. M., Ceccherini, I., Stulp, R. P., Stelwagen, T., Luo, Y., Pasini, B., Hoppener, J. W. M., van Amstel, H. K. P., Romeo, G., et al. (1994) · Nature · doi:10.1038/367375a0 · Cited by 1,149
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
Characterization of a multicomponent receptor for GDNF
Treanor, J. J. S., Goodman, L., de Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., Gray, C., Armanini, M. P., Pollock, R. A., Hefti, F., et al. (1996) · Nature · doi:10.1038/382080a0 · Cited by 1,080
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
Martin, G. A., Viskoohil, D., Bollag, G., McCabe, P. C., Crosier, W. J., Haubruck, H., Conroy, L., Clark, R., O'Connell, P., Cawthon, R. M., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90150-d · Cited by 982
Neumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Activation of a novel human transforming gene, ret, by DNA rearrangement
Takahashi, M., Ritz, J., & Cooper, G. M. (1985) · Cell · doi:10.1016/0092-8674(85)90115-1 · Cited by 854
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M., & Collins, F. (1990) · Cell · doi:10.1016/0092-8674(90)90151-4 · Cited by 847
Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R., & Johnson, E. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.1717 · Cited by 820
GDNF signalling through the Ret receptor tyrosine kinase
Durbec, P., Marcos-Gutierrez, C. V., Kilkenny, C., Grigoriou, M., Wartiowaara, K., Suvanto, P., Smith, D., Ponder, B., Costantini, F., Saarma, M., et al. (1996) · Nature · doi:10.1038/381789a0 · Cited by 811
Functional receptor for GDNF encoded by the c-ret proto-oncogene
Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.-S., Sieber, B.-A., Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Arumäe, U., et al. (1996) · Nature · doi:10.1038/381785a0 · Cited by 796
Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ
Zhao, C., Takita, J., Tanaka, Y., Setou, M., Nakagawa, T., Takeda, S., Yang, H. W., Terada, S., Nakata, T., Takei, Y., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00363-4 · Cited by 767
Mutations of the RET proto-oncogene in Hirschsprung's disease
Edery, P., Lyonnet, S., Mulligan, L. M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fékété, C., Ponder, B. A. J., & Munnich, A. (1994) · Nature · doi:10.1038/367378a0 · Cited by 749
Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 1×
“…years, homozygous and compound heterozygous mutations in the gene encoding the fourth subunit, SDHA, were associated with a rare early-onset R258 neurodegenerative disorder called Leigh syndrome (Bourgeron et al. 1995, Horvath et al. 2006), but neither with PCCs nor with PGLs (Bayley et al. 2005).”
BackgroundThe von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
Kaelin Jr, W. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2502 · Cited by 726
SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma
Hao, H.-X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J.-P., Kunst, H., Devilee, P., Cremers, C. W. R. J., Schiffman, J. D., Bentz, B. G., et al. (2009) · Science · doi:10.1126/science.1175689 · Cited by 702 · cited 11×
“The syndrome can be divided into PGL1, PGL2, PGL3, and PGL4, which are caused by mutations in SDHD, SDHAF2, SDHC, and SDHB respectively.”
BackgroundInfluentialRomeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M., Kääriäinen, H., et al. (1994) · Nature · doi:10.1038/367377a0 · Cited by 700
Genetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Lemos, M. C., & Thakker, R. V. (2008) · Human Mutation · doi:10.1002/humu.20605 · Cited by 675
Hirota, S., Ohashi, A., Nishida, T., Isozaki, K., Kinoshita, K., Shinomura, Y., & Kitamura, Y. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01046-1 · Cited by 666
SDHA is a tumor suppressor gene causing paraganglioma
Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaitre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 650
Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated Transcription
Agarwal, S. K., Guru, S. C., Heppner, C., Erdos, M. R., Collins, R. M., Park, S. Y., Saggar, S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80967-8 · Cited by 627
Benign Paragangliomas: Clinical Presentation and Treatment Outcomes in 236 Patients
Erickson, D. Z., Kudva, Y. C., Ebersold, M. J., Thompson, G. B., Grant, C. S., van Heerden, J. A., & Young, W. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5210 · Cited by 625
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaître, X. (2003) · PubMed · Cited by 609
The NF1 tumor suppressor critically regulates TSC2 and mTOR
Johannessen, C. M., Reczek, E. E., James, M. F., Brems, H., Legius, E., & Cichowski, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503224102 · Cited by 601
KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria
Nangaku, M., Sato-Yoshitake, R., Okada, Y., Noda, Y., Takemura, R., Yamazaki, H., & Hirokawa, N. (1994) · Cell · doi:10.1016/0092-8674(94)90012-4 · Cited by 598
Chen, H., Sippel, R. S., O'Dorisio, M. S., Vinik, A. I., Lloyd, R. V., & Pacak, K. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb4f0 · Cited by 593
Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
Benn, D. E., Gimenez-Roqueplo, A.-P., Reilly, J. R., Bertherat, J., Burgess, J., Byth, K., Croxson, M., Dahia, P. L. M., Elston, M., Gimm, O., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1862 · Cited by 570
Self-citationPROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J., Ter Wee, P., Meijer Truus, S., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 555
van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 538
Lee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M. S., Sajan, M. P., Farese, R. V., Freeman, R. S., Carter, B. D., Kaelin, W. G., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.015 · Cited by 527
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Comino-Méndez, I., Gracia-Aznárez, F. J., Schiavi, F., Landa, I., Leandro-García, L. J., Letón, R., Honrado, E., Ramos-Medina, R., Caronia, D., Pita, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.861 · Cited by 526
Hereditary cancer: Two hits revisited
Knudson, A. G. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01366952 · Cited by 491
Pasini, B., McWhinney, S. R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., Boikos, S. A., Ferrando, B., Pacak, K., Assie, G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201904 · Cited by 487
Boyd, K. P., Korf, B. R., & Theos, A. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.12.051 · Cited by 486
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
Trump, D., Farren, B., Wooding, C., Pang, J. T., Besser, G. M., Buchanan, K. D., Edwards, C. R., Heath, D. A., Jackson, C. E., Jansen, S., et al. (1996) · QJM · doi:10.1093/qjmed/89.9.653 · Cited by 471
Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease
Neumann, H., Berger, D. P., Sigmund, G., Blum, U., Schmidt, D., Parmer, R. J., Volk, B., & Kirste, G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292103 · Cited by 465
Clinical Experience Over 48 Years With Pheochromocytoma
Goldstein, R. E., O’Neill, J. A., Holcomb, G. W., Morgan, W. M., Neblett, W. W., Oates, J. A., Brown, N., Nadeau, J., Smith, B., Page, D. L., et al. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00001 · Cited by 464
Succinate dehydrogenase – Assembly, regulation and role in human disease
Rutter, J., Winge, D. R., & Schiffman, J. D. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.03.001 · Cited by 462
A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010008 · Cited by 443
Carney, J. A. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.6.543 · Cited by 435
National Cancer Data Base report on malignant paragangliomas of the head and neck
Lee, J. H., Barich, F., Karnell, L. H., Robinson, R. A., Zhen, W. K., Gantz, B. J., Hoffman, H. T., & American College of Surgeons Commission on Cancer and the American Cancer Society (2002) · Cancer · doi:10.1002/cncr.10252 · Cited by 427
Occurrence of Pheochromocytoma in Rochester, Minnesota, 1950 Through 1979
Beard, A. M., Sheps, S. G., Kurland, L. T., Carney, J. A., & Lie, J. T. (1983) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18873-3 · Cited by 402
Vanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381054 · Cited by 389
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
Qin, Y., Yao, L., King, E. E., Buddavarapu, K., Lenci, R. E., Chocron, E. S., Lechleiter, J. D., Sass, M., Aronin, N., Schiavi, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.533 · Cited by 379
Burnichon, N., Rohmer, V., Amar, L., Herman, P., Leboulleux, S., Darrouzet, V., Niccoli, P., Gaillard, D., Chabrier, G., Chabolle, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2504 · Cited by 378
Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics
Marx, S., Spiegel, A. M., Skarulis, M. C., Doppman, J. L., Collins, F. S., & Liotta, L. A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00011 · Cited by 368
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364
VON RECKLINGHAUSEN′S DISEASE AND PHEOCHROMOCYTOMAS
Walther, M. M., Herring, J., Enquist, E., Keiser, H. R., & Linehan, W. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68171-2 · Cited by 361
Familial paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney triad
Carney, J. A., & Stratakis, C. A. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10235 · Cited by 350
Germline SDHB Mutations and Familial Renal Cell Carcinoma
Ricketts, C., Woodward, E. R., Killick, P., Morris, M. R., Astuti, D., Latif, F., & Maher, E. R. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn254 · Cited by 342
Ricketts, C. J., Forman, J. R., Rattenberry, E., Bradshaw, N., Lalloo, F., Izatt, L., Cole, T. R., Armstrong, R., Kumar, V. K. A., Morrison, P. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21136 · Cited by 337
Schlisio, S., Kenchappa, R. S., Vredeveld, L. C. W., George, R. E., Stewart, R., Greulich, H., Shahriari, K., Nguyen, N. V., Pigny, P., Dahia, P. L., et al. (2008) · Genes & Development · doi:10.1101/gad.1648608 · Cited by 333
Percy, M. J., Zhao, Q., Flores, A., Harrison, C., Lappin, T. R. J., Maxwell, P. H., McMullin, M. F., & Lee, F. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508423103 · Cited by 330
Schiavi, F. (2005) · JAMA · doi:10.1001/jama.294.16.2057 · Cited by 329
PHD2 Mutation and Congenital Erythrocytosis with Paraganglioma
Ladroue, C., Carcenac, R., Leporrier, M., Gad, S., Le Hello, C., Galateau-Salle, F., Feunteun, J., Pouysségur, J., Richard, S., & Gardie, B. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806277 · Cited by 323
The diagnosis and management of malignant phaeochromocytoma and paraganglioma
Chrisoulidou, A., Kaltsas, G., Ilias, I., & Grossman, A. B. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-07-0074 · Cited by 314
Stratakis, C. A., & Carney, J. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02110.x · Cited by 312
Recent Progress in Hormone Research
Magid, G. J. (1967) · American Journal of Clinical Pathology · doi:10.1093/ajcp/48.1.48 · Cited by 310
GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY
Van Der Mey, A. L., Maaswinkel-Mooy, P., Cornelisse, C., Schmidt, P., & Van De Kamp, J. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91908-9 · Cited by 305
Mannelli, M., Castellano, M., Schiavi, F., Filetti, S., Giacchè, M., Mori, L., Pignataro, V., Bernini, G., Giachè, V., Bacca, A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2419 · Cited by 303
High altitude hypoxia and chemodectomas
Saldana, M. J., Salem, L. E., & Travezan, R. (1973) · Human Pathology · doi:10.1016/s0046-8177(73)80012-7 · Cited by 298
Eisenhofer, G., Lenders, J. W., Timmers, H., Mannelli, M., Grebe, S. K., Hofbauer, L. C., Bornstein, S. R., Tiebel, O., Adams, K., Bratslavsky, G., et al. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.153320 · Cited by 290
Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.-P., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1043 · Cited by 277
Gill, A. J., Benn, D. E., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G. Y., Richardson, A. L., Sidhu, S. B., Robinson, B. G., & Clifton-Bligh, R. J. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.12.005 · Cited by 277
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma
Bayley, J.-P., Kunst, H. P., Cascon, A., Sampietro, M. L., Gaal, J., Korpershoek, E., Hinojar-Gutierrez, A., Timmers, H. J., Hoefsloot, L. H., Hermsen, M. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70007-3 · Cited by 276
Gimm, O., Armanios, M. Y., Dziema, H., Neumann, H. P. H., & Eng, C. (2000) · PubMed · Cited by 274
Self-citationWALTHER, M. M., REITER, R., KEISER, H. R., CHOYKE, P. L., VENZON, D., HURLEY, K., GNARRA, J. R., REYNOLDS, J. C., GLENN, G. M., ZBAR, B., et al. (1999) · Journal of Urology · doi:10.1097/00005392-199909010-00004 · Cited by 255
Besset, V., Scott, R. P., & Ibáñez, C. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006908200 · Cited by 255
Zhu, J., Blenis, J., & Yuan, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802785105 · Cited by 246
Ghezzi, D., Goffrini, P., Uziel, G., Horvath, R., Klopstock, T., Lochmüller, H., D'Adamo, P., Gasparini, P., Strom, T. M., Prokisch, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.378 · Cited by 246
Germline SDHD mutation in familial phaeochromocytoma
Astuti, D., Douglas, F., Lennard, T. W., Aligianis, I. A., Woodward, E. R., Evans, D. G. R., Eng, C., Latif, F., & Maher, E. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04378-6 · Cited by 246
The Warburg effect is genetically determined in inherited pheochromocytomas
Favier, J., Brière, J.-J., Burnichon, N., Rivière, J., Vescovo, L., Benit, P., Giscos-Douriez, I., De Reyniès, A., Bertherat, J., Badoual, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007094 · Cited by 232
Waguespack, S. G., Rich, T., Grubbs, E., Ying, A. K., Perrier, N. D., Ayala-Ramirez, M., & Jimenez, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2830 · Cited by 232
Metabolic transformation in cancer
Tennant, D. A., Duran, R. V., Boulahbel, H., & Gottlieb, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp070 · Cited by 225
Familial Gastrointestinal Stromal Tumors and Germ-Line Mutations
McWhinney, S. R., Pasini, B., & Stratakis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmc071191 · Cited by 224
Segouffin-Cariou, C., & Billaud, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3568 · Cited by 223
Management of Pheochromocytomas in Patients with Multiple Endocrine Neoplasia Type 2 Syndromes
Lairmore, T. C., Ball, D. W., Baylin, S. B., & Wells, S. A. (1993) · Annals of Surgery · doi:10.1097/00000658-199306000-00001 · Cited by 218
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Prowse, A. H., Webster, A. R., Richards, F. M., Richard, S., Olschwang, S., Resche, F., Affara, N. A., & Maher, E. R. (1997) · Europe PMC (PubMed Central) · Cited by 215
Pheochromocytoma in Sweden 1958–1981: An Analysis of the National Cancer Registry Data
STENSTRÖM, G., & SVÅRDSUDD, K. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02755.x · Cited by 213
Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data.
Stenström, G., & Svardsudd, K. F. (1986) · PubMed · Cited by 212
López-Jiménez, E., Gómez-López, G., Leandro-García, L. J., Muñoz, I., Schiavi, F., Montero-Conde, C., de Cubas, A. A., Ramires, R., Landa, I., Leskelä, S., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0256 · Cited by 209
Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level
Rodríguez-Cuevas, S., López-Garza, J., & Labastida-Almendaro, S. (1998) · Head & Neck · doi:10.1002/(sici)1097-0347(199808)20:5<374::aid-hed3>3.0.co;2-v · Cited by 209
Eisenhofer, G., Huynh, T.-T., Pacak, K., Brouwers, F. M., Walther, M. M., Linehan, W. M., Munson, P. J., Mannelli, M., Goldstein, D. S., & Elkahloun, A. G. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00838 · Cited by 207
Kopetschke, R., Slisko, M., Kilisli, A., Tuschy, U., Wallaschofski, H., Fassnacht, M., Ventz, M., Beuschlein, F., Reincke, M., Reisch, N., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0384 · Cited by 204
TORC1 Is Essential for NF1-Associated Malignancies
Johannessen, C. M., Johnson, B. W., Williams, S. M. G., Chan, A. W., Reczek, E. E., Lynch, R. C., Rioth, M. J., McClatchey, A., Ryeom, S., & Cichowski, K. (2008) · Current Biology · doi:10.1016/j.cub.2007.11.066 · Cited by 203
Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas
Yao, L., Schiavi, F., Cascon, A., Qin, Y., Inglada-Pérez, L., King, E. E., Toledo, R. A., Ercolino, T., Rapizzi, E., Ricketts, C. J., et al. (2010) · JAMA · doi:10.1001/jama.2010.1830 · Cited by 202
Clinical Spectrum and Outcome of Functional Extraadrenal Paraganglioma
O’Riordain, D. S., Young, W. F., Grant, C. S., Carney, J. A., & van Heerden, J. A. (1996) · World Journal of Surgery · doi:10.1007/s002689900139 · Cited by 201
Ichihara, M. (2004) · Cancer Letters · doi:10.1016/s0304-3835(03)00456-7 · Cited by 197
Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland
McNeil, A. R., Blok, B. H., Koelmeyer, T. D., Burke, M. P., & Hilton, J. M. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb04358.x · Cited by 195
Multiple endocrine neoplasia type 1: new clinical and basic findings
Schussheim, D. H., Skarulis, M. C., Agarwal, S. K., Simonds, W. F., Burns, A. L., Spiegel, A. M., & Marx, S. J. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00372-6 · Cited by 188
Bayley, J.-P., Devilee, P., & Taschner, P. E. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-39 · Cited by 184
The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1
Carty, S. E., Helm, A. K., Amico, J. A., Clarke, M. R., Foley, T. P., Watson, C. G., & Mulvihill, J. J. (1998) · Surgery · doi:10.1067/msy.1998.93107 · Cited by 182
The pressure rises: update on the genetics of phaeochromocytoma
Maher, E. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2347 · Cited by 176
Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients
Erlic, Z., Rybicki, L., Peczkowska, M., Golcher, H., Kann, P. H., Brauckhoff, M., Müssig, K., Muresan, M., Schäffler, A., Reisch, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1237 · Cited by 175
Strong, V. E., Kennedy, T., Al-Ahmadie, H., Tang, L., Coleman, J., Fong, Y., Brennan, M., & Ghossein, R. A. (2008) · Surgery · doi:10.1016/j.surg.2008.02.007 · Cited by 174
Sj, M., Agarwal, S. K., Kester, M. B., Heppner, C., Ys, K., Skarulis, M. C., La, J., Goldsmith, P. K., Saggar, S. K., Sy, P., et al. (1999) · PubMed · Cited by 173
Brière, J.-J., Favier, J., Bénit, P., Ghouzzi, V. E., Lorenzato, A., Rabier, D., Renzo, M. F. D., Gimenez‐Roqueplo, A., & Rustin, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi359 · Cited by 173
Pheochromocytoma in multiple endocrine neoplasia type 2: European study
Modigliani, E., VASEN, H. M., RAUE, K., DRALLE, H., FRILLING, A., GHERI, R. G., BRANDI, M. L., LIMBERT, E., NIEDERLE, B., FORGAS, L., et al. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01211.x · Cited by 172
Vogel, K. S., Brannan, C. I., Jenkins, N. A., Copeland, N. G., & Parada, L. F. (1995) · Cell · doi:10.1016/0092-8674(95)90470-0 · Cited by 166
SDHAF2 (PGL2-SDH5) and Hereditary Head and Neck Paraganglioma
Kunst, H. P. M., Rutten, M., de Mönnink, J. P., Hoefsloot, L. H., Timmers, H. J. L. M., Marres, H. A. M., Jansen, J. C., Kremer, H., Bayley, J., & Cremers, C. W. R. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0420 · Cited by 163
A germline mutation of the KIF1Bβ gene on 1p36 in a family with neural and nonneural tumors
Yeh, I., Lenci, R., Qin, Y., Buddavarapu, K., Ligon, A. H., Leteurtre, E., Cao, C. D., Cardot-Bauters, C., Pigny, P., & Dahia, P. L. M. (2008) · Human Genetics · doi:10.1007/s00439-008-0553-1 · Cited by 161
The role of hypoxia-inducible factors in cancer
Maynard, M. A., & Ohh, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7082-2 · Cited by 154
Pollard, P. J., El-Bahrawy, M. A., Poulsom, R., Elia, G., Killick, P., Kelly, G. P., Hunt, T., Jeffery, R. E., Seedhar, P., Barwell, J., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0920 · Cited by 154
Matyakhina, L., Bei, T. A., McWhinney, S. R., Pasini, B., Cameron, S., Gunawan, B., Stergiopoulos, S. G., Boikos, S. A., Muchow, M., Dutra, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0797 · Cited by 152
Pantaleo, M. A., Astolfi, A., Indio, V., Moore, R. A., Thiessen, N., Heinrich, M. C., Gnocchi, C., Santini, D., Catena, F., Formica, S., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr130 · Cited by 150
Crossey, P. A., Foster, K., Richards, F. M., Phipps, M. E., Latif, F., Tory, K., Jones, M. H., Bentley, E., Kumar, R., Lerman, M., et al. (1994) · Human Genetics · doi:10.1007/bf00218913 · Cited by 148
Bausch, B., Borozdin, W., Mautner, V. F., Hoffmann, M. M., Böhm, D., Robledo, M., Cascón, A., Harenberg, T., Schiavi, F., Pawlu, C., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2833 · Cited by 146
Self-citationPierchala, B. A., Milbrandt, J., & Johnson, E. M. (2002) · Neuron · doi:10.1016/s0896-6273(01)00585-2 · Cited by 146
Pheochromocytoma: an update on genetics and management
Karagiannis, A. I., Mikhailidis, D. P., Athyros, V. G., & Harsoulis, F. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0142 · Cited by 145
Genetics of pheochromocytoma and paraganglioma in Spanish patients.
Cascón, A., Pita, G., Burnichon, N., Landa, I., López-Jiménez, E., Montero-Conde, C., Leskelä, S., Leandro-García, L., Letón, R., Rodríguez-Antona, C., et al. (2009) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2008-2756 · Cited by 143
c-junis essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation
Palmada, M., Kanwal, S., Rutkoski, N. J., Gustafson‐Brown, C., Johnson, R. S., Wisdom, R., & Carter, B. D. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200112129 · Cited by 139
Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2
Boedeker, C. C., Erlic, Z., Richard, S., Kontny, U., Gimenez‐Roqueplo, A., Cascón, A., Robledo, M., de Campos, J. M., van Nederveen, F. H., de Krijger, R. R., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0354 · Cited by 138
Update multiple endocrine neoplasia type 2
Raue, F., & Frank‐Raue, K. (2010) · Familial Cancer · doi:10.1007/s10689-010-9320-2 · Cited by 134
Horváth, R. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.067041 · Cited by 133
Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL
Woodward, E. R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1051 · Cited by 125
Pheochromocytomas: The (pseudo)-hypoxia hypothesis
Favier, J., & Gimenez‐Roqueplo, A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.004 · Cited by 124
Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation
Pęczkowska, M., Cascón, A., Prejbisz, A., Kubaszek, A., Ćwikła, J. B., Furmanek, M. I., Erlic, Z., Eng, C., Januszewicz, A., & Neumann, H. P. H. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0726 · Cited by 108
Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis
Richards, F., Schofield, P. N., Fleming, S., & Maher, E. R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.639 · Cited by 104
Pheochromocytoma penetrance varies by RET mutation in MEN 2A
Quayle, F. J., Fialkowski, E., Benveniste, R. J., & Moley, J. F. (2007) · Surgery · doi:10.1016/j.surg.2007.09.013 · Cited by 103
Bender, B., Gutsche, M., Gläsker, S., Müller, B., Kirste, G. R., Eng, C., & Neumann, H. P. H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7015 · Cited by 103
Munirajan, A. K., Ando, K., Mukai, A., Takahashi, M., Suenaga, Y., Ohira, M., Koda, T., Hirota, T., Ozaki, T., & Nakagawara, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802316200 · Cited by 101
Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects
Zinnamosca, L., Petramala, L., Cotesta, D., Marinelli, C., Schina, M., Cianci, R., Giustini, S., Sciomer, S., Anastasi, E., Calvieri, S., et al. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1090-z · Cited by 100
Neumann, H. P. H., Sullivan, M., Winter, A., Malinoc, A., Hoffmann, M. M., Boedeker, C. C., Bertz, H., Walz, M. K., Moeller, L. C., Schmid, K. W., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0114 · Cited by 98
Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics
Dahia, P. L. M., Hao, K., Rogus, J. J., Colin, C., Pujana, M. Á., Ross, K. N., Magoffin, D. E., D, N. A. M., Cascón, A., Hayashida, C. Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1427 · Cited by 97
Douwes Dekker, P., Hogendoorn, P., Kuipers‐Dijkshoorn, N., Prins, F., van Duinen, S., Taschner, P., van der Mey, A., & Cornelisse, C. (2003) · The Journal of Pathology · doi:10.1002/path.1461 · Cited by 94
Genetic screening for pheochromocytoma: should SDHC gene analysis be included?: Figure 1
Mannelli, M., Ercolino, T., Giaché, V., Simi, L., Cirami, C. L., & Parenti, G. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.051045 · Cited by 94
Phaeochromocytomas presenting as acute crises after beta blockade therapy
Sibal, L., Jovanović, A., Agarwal, S. C., Peaston, R., James, R. A., Lennard, T. W. J., Bliss, R., Batchelor, A. M., & Perros, P. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02571.x · Cited by 94
Srirangalingam, U., Walker, L., Khoo, B. C. E., MacDonald, F., Gardner, D. S.-L., Wilkin, T. J., Skelly, R. H., George, E., Spooner, D. A., Monson, J. P., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03274.x · Cited by 93
The Nerve Growth Factor-Responsive PC12 Cell Line Does Not Express the Myc Dimerization Partner Max
Hopewell, R., & Ziff, E. B. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3470 · Cited by 91
Von Hippel-Lindau disease and endocrine tumour susceptibility
Woodward, E. R., & Maher, E. R. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.00683 · Cited by 90
Paraganglioma after Maternal Transmission of a Succinate Dehydrogenase Gene Mutation
Pigny, P., Vincent, A., Bauters, C. C., Bertrand, M., de Montpréville, V., Crepin, M., Porchet, N., & Caron, P. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1989 · Cited by 86
Pheochromocytoma: Clinical Observations from a Brooklyn Tertiary Hospital
Ariton, M., JUAN, C. S., & AvRuskin, T. W. (2000) · Endocrine Practice · doi:10.4158/ep.6.3.249 · Cited by 86
Pheochromocytoma as the first manifestation of von Hippel-Lindau disease.
Richard, S., Beigelman‐Aubry, C., Duclos, J. M., Fendler, J. P., Plauchu, H., Plouin, P., Resche, F., Schlumberger, M. J., Vermesse, B., & Proye, C. (1994) · PubMed · Cited by 85
Niemann, S., Müller, U., Engelhardt, D., & Lohse, P. (2003) · Human Genetics · doi:10.1007/s00439-003-0938-0 · Cited by 82
Dannenberg, H., Dinjens, W. N. M., Abbou, M., van Urk, H., Pauw, B. K. H., Mouwen, D., Mooi, W. J., & de Krijger, R. R. (2002) · PubMed · Cited by 81
Pheochromocytoma in MEN 2A Syndrome. Study of 54 Patients
Rodríguez, J. M., Balsalobre, M. D., Ponce, J. L., Ríos, A., Torregrosa, N. M., Tébar, J., & Parrilla, P. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9734-2 · Cited by 79
Kehrer‐Sawatzki, H., & Cooper, D. N. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059329 · Cited by 78
SomaticSDHBMutation in an Extraadrenal Pheochromocytoma
van Nederveen, F. H., Korpershoek, E., Lenders, J. W. M., de Krijger, R. R., & Dinjens, W. N. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070010 · Cited by 73
Bender, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4568 · Cited by 70
Genetic Testing for Pheochromocytoma
Karásek, D., Fryšák, Z., & Pacák, K. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0151-1 · Cited by 67
Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells
Califano, D., Rizzo, C., D'Alessio, A., Colucci-D'Amato, G. L., Calı̀, G., Bartoli, P. C., Santelli, G., Vecchio, G., & de Franciscis, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m905866199 · Cited by 67
Screening for MEN1 mutations in patients with atypical endocrine neoplasia
Dackiw, A. P. B., Cote, G. J., Fleming, J. B., Schultz, P. N., Stanford, P., Vassilopoulou‐Sellin, R., Evans, D. B., Gagel, R. F., & Lee, J. E. (1999) · Surgery · doi:10.1067/msy.2099.101376 · Cited by 66
The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation
Peterson, S., & Bogenmann, E. (2004) · Oncogene · doi:10.1038/sj.onc.1206980 · Cited by 65
Phaeochromocytomas and sympathetic paragangliomas
Petri, B., van Eijck, C. H. J., de Herder, W. W., Wagner, A., & de Krijger, R. R. (2009) · British journal of surgery · doi:10.1002/bjs.6821 · Cited by 65
Astuti, D., Ricketts, C. J., Chowdhury, R., McDonough, M. A., Gentle, D., Kirby, G. A., Schlisio, S., Kenchappa, R. S., Carter, B. D., Kaelin, W. G., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0113 · Cited by 60
Favia, G., Lumachi, F., Polistina, F., et al. (1998) · World Journal of Surgery · doi:10.1007/s002689900454 · Cited by 53
Minireview: The Busy Road to Pheochromocytomas and Paragangliomas Has a New Member, TMEM127
Jiang, S., & Dahia, P. L. M. (2011) · Endocrinology · doi:10.1210/en.2011-0052 · Cited by 47
A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma
Burnichon, N., Lussey‐Lepoutre, C., Laffaire, J., Gadessaud, N., Molinié, V., Hernigou, A., Plouin, P., Jeunemaître, X., Favier, J., & Gimenez‐Roqueplo, A. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0758 · Cited by 46
SDHC mutation in an elderly patient without familial antecedents
López-Jiménez, E. A., de Campos, J. M., Kusak, E., Landa, I., Leskelä, S., Montero‐Conde, C., Leandro-Garcia, L. J., Vallejo, L. A., Madrigal, B., Rodríguez‐Antona, C., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03368.x · Cited by 44
The MEN1 Gene and Pituitary Tumours
Agarwal, S. K., Ozawa, A., Mateo, C. M., & Marx, S. J. (2009) · Hormone Research in Paediatrics · doi:10.1159/000192450 · Cited by 42
Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma
Korpershoek, E., Petri, B., van Nederveen, F. H., Dinjens, W. N. M., Verhofstad, A. A. J., de Herder, W. W., Schmid, S., Perren, A. A., Komminoth, P., & de Krijger, R. R. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0044 · Cited by 37
Vaque, J. P., Fernández‐García, B., García‐Sanz, P., Ferrándiz, N., Bretones, G., Calvo, F., Crespo, P., Marín, M. C., & León, J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0180 · Cited by 36
Differential Diagnosis of Pheochromocytomas and Paragangliomas
McNicol, A. M. (2001) · Endocrine Pathology · doi:10.1385/ep:12:4:407 · Cited by 34
Lips, C. J. M., Lentjes, E. G. W. M., Höppener, J. W. M., van der Luijt, R. B., & Moll, F. L. (2006) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-4-4-169 · Cited by 30
Yao, L., Barontini, M., Niederle, B., Jech, M., Pfragner, R., & Dahia, P. L. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2245 · Cited by 29
Waldmann, J., Langer, P., Habbe, N., Fendrich, V., Ramaswamy, A., Rothmund, Μ., Bartsch, D. K., & Slater, E. P. (2009) · Endocrine · doi:10.1007/s12020-009-9178-y · Cited by 21
Hensen, E. F., Goeman, J. J., Oosting, J., van der Meij, A. G. L., Hogendoorn, P. C. W., Cremers, C. W. R. J., Devilee, P., & Cornelisse, C. J. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-25 · Cited by 17
JunD-Menin Interaction Regulates c-Jun-mediated AP-1 Transactivation
IKEO, Y., Yumita, W., Sakurai, A., & Hashizume, K. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.333 · Cited by 11
Cited by
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., Blowey, D., Carroll, A. E., Daniels, S. R., de Ferranti, S. D., Dionne, J. M., Falkner, B., Flinn, S. K., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1904 · Cited by 3,651
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Dahia, P. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3648 · Cited by 545
Mitochondrial complex ii: At the crossroads
Bezawork-Geleta, A., Rohlena, J., Dong, L., Pacak, K., & Neuzil, J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.003 · Cited by 295
The NGS in PPGL (NGSnPPGL) Study Group, Toledo, R. A., Burnichon, N., Cascon, A., Benn, D. E., Bayley, J.-P., Welander, J., Tops, C. M., Firth, H., Dwight, T., et al. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.185 · Cited by 275
Self-citation
Metadata
- Authors
- Welander, J., Söderkvist, P., & Gimm, O.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2011-10-31
- Volume
- 18
- Issue
- 6
- Pages
- R253-R276
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2125170852
- Cited by
- 355
- References
- 179
- FWCI
- 25.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.